ReviewAnti-cancer drugs2016

RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.

Mark A WeinbergPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.